Evidence map›Paper›PMID 20535599›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2010

BAG3 protein delocalisation in prostate carcinoma.

Stefania Staibano, Massimo Mascolo, Maria Di Benedetto, Maria Luisa Vecchione, Gennaro Ilardi, Giuseppe Di Lorenzo, Riccardo Autorino, Vincenzo Salerno, Antonella Morena, Alba Rocco and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Review
  3. BAG3 in human tumors.Frontiers in oncology · 2025
    Article
  4. BAG family proteins contributes to autophagy-mediated multidrug resistance of tumor.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. High expression of BAG3 predicts a poor prognosis in human medulloblastoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  13. The critical role of HMGA2 in regulation of EMT in epithelial ovarian carcinomas.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  14. BAG3 protects against hyperthermic stress by modulating NF-κB and ERK activities in human retinoblastoma cells.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2015
    Article
  15. BAG3 regulates epithelial-mesenchymal transition and angiogenesis in human hepatocellular carcinoma.Laboratory investigation; a journal of technical methods and pathology · 2014
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Stefania StaibanoDepartment of Biomorphological and Functional Sciences, Pathology Section, University Federico II of Naples, School of Medicine, Via S. Pansini, 5, 80131, Naples, Italy. staibano@unina.it
Massimo Mascolo
Maria Di Benedetto
Maria Luisa Vecchione
Gennaro Ilardi
Giuseppe Di Lorenzo
Riccardo Autorino
Vincenzo Salerno
Antonella Morena
Alba Rocco
Maria Caterina Turco
Emilio Morelli
University of Naples Federico II · ITSanta Maria Nuova Hospital · ITUniversity of Salerno · ITUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the progressive increase of early diagnosis, a subset of prostate cancers show a metastasizing and lethal course, not always predictable upon the traditional prognostic parameters. The object of this study was to investigate the role of the survival co-chaperone protein BAG3 as a new prognostic marker for prostate cancer. BAG3 was detected by immunohistochemistry in 55 specimens of surgically removed prostate carcinomas and in 15 surgical specimens of non-neoplastic prostate tissues. Results were compared with clinic-pathological data and outcome of patients and statistically evaluated. BAG3 resulted expressed in all the cases: Non-neoplastic prostate tissue showed a cytoplasmatic staining with apical reinforcement, a finding which appears consistent with the reported connection of the protein with the membrane focal cell-adhesion complexes. In prostate carcinomas, BAG3 showed a progressive decrease of the expression level from well- to low-differentiated carcinoma, coupled with the loss of polarisation of the signal in metastasizing cases. These results indicate that BAG3 intra-cytoplasmic delocalisation is a specific feature of cancer versus non-neoplastic prostate and a candidate new marker for prediction of prostate cancer invasiveness and behaviour.

Indexed as

Adaptor Proteins, Signal TransducingAdenocarcinomaAgedAged, 80 and overApoptosis Regulatory ProteinsBiomarkers, TumorDisease-Free SurvivalHumansImmunohistochemistryKaplan-Meier EstimateMaleMiddle AgedNeoplasm StagingPrognosisProstatic NeoplasmsAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsBAG3 protein, humanBiomarkers, Tumor

Identifiers

PMID20535599
OpenAlexW2005314893

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.